CVS Health has been accused of overcharging for generic medications in a new lawsuit brought forth by six Blue Cross Blue Shield plans.

More than 1,750 standalone Medicare Part D prescription drug plans and MA plans have applied to offer insulin at a maximum $35 copay for a month’s supply of the drug for the 2021 plan year, CMS announced.

The healthcare sector has seen an influx of funding from private equity groups over the last several years, aiding in the contraction of the industry. But has the influence of cash been beneficial for healthcare?

CVS Health has stated it will return $43 million in funding it received for COVID-19 relief.

Hospitals and healthcare providers are facing higher costs to care for complex COVID-19 patients while also suffering the loss of other procedures like elective surgeries that could help offset these higher costs.

Plummeting healthcare spending due to COVID-19 had much to do with the U.S. gross domestic product falling 4.8% the first quarter of this year—and April’s report may bring no relief.  

Dedalus Group chairman Giorgio Moretti expresses pride over the deal going through despite the challenges COVID-19 has posed to Italy’s healthcare system and economy.

Private health insurers will bank a collective $12 billion windfall after the U.S. Supreme Court ruled Monday, 8 to 1, that they’re entitled to federal compensation for money they were promised to help stand up the Affordable Care Act.